The FASEB Journal · 2002 · 96 citations · 43 references
Life SciencesCardiologyPhysiologyCell SignalingGene ExpressionMolecular PhysiologyCalcium SignalingCalcium Transport ProteinsCardiac Ion ChannelsDiabetes MellitusIon Channel ExpressionIon Channel RegulationCalcium AtpaseCardiac Contractile Protein RegulationCardiac Ion Channel RegulationCardiomyocyte EnergeticsDiabetic CardiomyopathyHeart ChambersSarcoplasmic Reticulum Calcium AtpasesTransgene Expression
ABSTRACT Slowed relaxation in diabetic cardiomyopathy (CM) is partially related to diminished expression of the sarcoplasmic reticulum (SR) Ca 2+ ‐ATPase SERCA2a. To evaluate the impact of SERCA2a overexpression on SR Ca 2+ handling in diabetic CM, we 1) generated transgenic rats harboring a human cytomegalovirus enhancer/chicken β‐actin promotor‐controlled rat SERCA2 transgene (SERCA2‐TGR), 2) characterized their SR phenotype, and 3) examined whether transgene expression may rescue SR Ca 2+ transport in streptozotocin‐induced diabetes. The transgene was expressed in all heart chambers. Compared to wild‐type (WT) rats, a heterozygous line exhibited increased SERCA2 mRNA (1.5‐fold), SERCA2 protein (+26%) and SR Ca 2+ uptake (+37%). Phospholamban expression was not altered. In SERCA2‐TGR, contraction amplitude (+48%) and rates of contraction (+34%) and relaxation (+35%) of isolated papillary muscles (PM) were increased ( P <0.05 vs. WT, respectively); the lusitropic and inotropic responses of PM to forskolin were stronger than in WT. In diabetic myocardium with SR dysfunction, Ca 2+ uptake and SERCA2 protein of SERCA2‐TGR were 1.3‐fold higher ( P <0.05 vs. diabetic WT). Thus, a SERCA2 overexpression in rat heart improves Ca 2+ uptake, accelerates relaxation and compensates, in part, for depressed Ca 2+ uptake in diabetic CM. Therefore, SERCA2 expression might constitute an important therapeutic target to rescue cardiac SR Ca 2+ handling in diabetes.
43
Peter Richardson, William J. McKenna, Michael R. Bristow et al. · Circulation · 1996 · 3.5K citations